OpenAlex
PricingAboutJobs
Log inGet started
Work

ALK1 as an emerging target for antiangiogenic therapy of cancer

HTML

Year: 2011
Type: review
Source: Blood
DOI: 10.1182/blood-2011-01-330142
Authors: Sara I. Cunha, Kristian Pietras
Institution: Karolinska Institutet
Language: English

Topic: TGF-β signaling in diseases
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: ALK1, TGF-beta type I receptor, anti-angiogenic therapy, tumor angiogenesis, BMP9, BMP10, TGF-beta signaling, endothelial cells, tumor vascularization
SDG: Good health and well-being

Open Access status: green

Funders: Ludwig Institute for Cancer Research, Acceleron, Cancerfonden, Karolinska Institutet
OpenAlex ID: W2078139160
FWCI: 1.438
Cites: 90
Cited by: 205
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security